0001209191-24-001801.txt : 20240117 0001209191-24-001801.hdr.sgml : 20240117 20240117190045 ACCESSION NUMBER: 0001209191-24-001801 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240112 FILED AS OF DATE: 20240117 DATE AS OF CHANGE: 20240117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DeVaul William CENTRAL INDEX KEY: 0001780270 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38940 FILM NUMBER: 24539725 MAIL ADDRESS: STREET 1: C/O MORPHIC HOLDING, INC. STREET 2: 35 GATEHOUSE DRIVE, A2 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Morphic Holding, Inc. CENTRAL INDEX KEY: 0001679363 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473878772 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 GATEHOUSE DRIVE A2 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 996-0955 MAIL ADDRESS: STREET 1: 35 GATEHOUSE DRIVE A2 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Morphic Holding, LLC DATE OF NAME CHANGE: 20160712 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-01-12 0 0001679363 Morphic Holding, Inc. MORF 0001780270 DeVaul William C/O MORPHIC HOLDING, INC. 35 GATEHOUSE DRIVE, A2 WALTHAM MA 02451 0 1 0 0 General Counsel and Secretary 0 Common Stock 2024-01-13 4 M 0 10950 0.00 A 24288 D Common Stock 2024-01-14 4 M 0 3250 0.00 A 27538 D Common Stock 2024-01-16 4 S 0 4509 27.4907 D 23029 D Stock Option (right to buy Common Stock) 27.79 2024-01-12 4 A 0 69600 0.00 A 2034-01-11 Common Stock 69600 69600 D Restricted Stock Unit 2024-01-12 4 A 0 44400 0.00 A Common Stock 44400 44400 D Restricted Stock Unit 2024-01-13 4 M 0 10950 0.00 D Common Stock 10950 32850 D Restricted Stock Unit 2024-01-14 4 M 0 3250 0.00 D Common Stock 3250 6500 D Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. The option vests as to 2.0833% of the total shares monthly, beginning February 12, 2024, with 100% of the total shares vested and exercisable on January 12, 2028, subject to the reporting person's provision of service to the issuer on each vesting date. The RSUs vest as to 25% of the total shares on each of January 12, 2025, January 12, 2026, January 12, 2027 and January 12, 2028, subject to the reporting person's provision of service to the issuer on each vesting date. The RSUs vest as to 25% of the total shares on each of January 13, 2024, January 13, 2025, January 13, 2026 and January 13, 2027, subject to the reporting person's provision of service to the issuer on each vesting date. The RSUs vest as to 25% of the total shares on each of January 14, 2023, January 14, 2024, January 14, 2025 and January 14, 2026, subject to the reporting person's provision of service to the issuer on each vesting date. /s/ Robert Farrell as attorney-in-fact for William DeVaul 2024-01-17